Markus Manz

70PUBLICATIONS

300CO-AUTHORS

Predictive and prognostic markersHaematological tumoursMedical mycologyCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (70)

Sort by Publication Date:

|Jul 13, 2026

A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

|Jun 17, 2026

Class 3 MAP2K1 mutations are associated with frequent relapse and multiple treatment lines in multi-system Langerhans cell histiocytosis.

|Jun 08, 2026

Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

|May 28, 2026

CD117-targeted HCT preconditioning in AML and MDS.

|May 11, 2026

A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

|May 07, 2026

CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

Pageof 12

Frequent Collaborators

12 joint publications

Christian Pellegrino

Francisco Caiado

Bob Löwenberg

Dario Neri

Steffen Boettcher

Christian Koch

Thomas Pabst

Laura Volta

Florin Schneiter

César Nombela-Arrieta

Frequent Collaborators

12 joint publications

Christian Pellegrino

9 joint publications

Francisco Caiado

9 joint publications

Bob Löwenberg

9 joint publications

Dario Neri